The New York Times logo

The New York Times Journo Requests

Connect directly with The New York Times journalists and editors. From breaking news to feature stories, discover journo opportunities from this trusted publication.

Latest The New York Times Journo Requests

Pancreatic Cancer Patients Seeking Daraxonrasib - Phase 3 Reaction

New York Times reporter looking to interview people seeking daraxonrasib Hi, everyone. My name is Rebecca Robbins, and I'm a reporter with The New York Times. I write about medicines and the pharmaceutical industry for the newspaper. You can learn more about what I write about here: https://www.nytimes.com/by/rebecca-robbins I asked and received permission to post here from one of the moderators of this subreddit for a story I'm working on about daraxonrasib. We're hoping to talk to people with pancreatic cancer who want to try daraxonrasib. We're interested in talking both to people who have been seeking the drug for months, as well as those who only recently became interested in light of the very encouraging Phase 3 RASolute 302 clinical trial data that Revolution Medicines announced on April 13 (https://ir.revmed.com/news-releases/news-release-details/daraxonrasib-demonstrates-unprecedented-overall-survival-benefit). We would also be interested in speaking with people who participated in the Phase 3 RASolute 302 clinical trial, whether in the intervention arm or the standard care arm. If you would be interested in being interviewed, you can reach out to me at [email redacted] or text or call me at 714-478-4224. We can then set up a phone call or video conference in the next few days for the interview. For this story, we are looking to speak with people who open to potentially having their names published in the newspaper. Thank you for your consideration.

nytimes.com logonytimes.com

We Monitor the Web for The New York Times Journo Requests

Never Miss a The New York Times Journo Request

Get instant alerts when The New York Times journalists post new journo requests. Join the community of sources landing media opportunities daily.